The Montreal Neurological Institute-Hospital, also known as Montreal Neuro or The Neuro, is a research and medical centre dedicated to neuroscience, training and clinical care, located in the city's downtown core of Montreal, Quebec, Canada.

There are 85 beds in Montreal Neurological Institute and Hospital.

During the past decade, Montreal Neurological Institute and Hospital conducted 77 clinical trials. In the 10-year time frame, 77 clinical trials started and 40 clinical trials were completed, i.e. on average, 51.9% percent of trials that started reached the finish line to date. In the past 5 years, 35 clinical trials started and 24 clinical trials were completed. i.e. 68.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Montreal Neurological Institute and Hospital" #1 sponsor was "Hoffmann-La Roche" with 9 trials, followed by "McGill University" with 7 trials sponsored, "Cytokinetics" with 6 trials sponsored, "Biogen" with 4 trials sponsored and "Genentech, Inc." with 4 trials sponsored. Other sponsors include 77 different institutions and companies that sponsored additional 68 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Montreal Neurological Institute and Hospital" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 5 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 5 trials as a collaborator, "University of Calgary" with 5 trials as a collaborator, "Emissary International LLC" with 3 trials as a collaborator and "Genentech, Inc." with 3 trials as a collaborator. Other collaborators include 64 different institutions and companies that were collaborators in the rest 66 trials.

According to Clinical.Site data, the most researched conditions in "Montreal Neurological Institute and Hospital" are "Amyotrophic Lateral Sclerosis" (22 trials), "Multiple Sclerosis" (11 trials), "ALS" (6 trials), "Glioblastoma" (5 trials) and "Glioblastoma Multiforme" (5 trials). Many other conditions were trialed in "Montreal Neurological Institute and Hospital" in a lesser frequency.

Most popular intervention types in "Montreal Neurological Institute and Hospital" are "Drug" (86 trials), "Other" (17 trials), "Biological" (10 trials), "Device" (9 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (34 trials), "Ocrelizumab" (9 trials), "Temozolomide" (5 trials), "Losmapimod" (3 trials) and "MT-1186" (3 trials). Other intervention names were less common.

The vast majority of trials in "Montreal Neurological Institute and Hospital" are 111 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Montreal Neurological Institute and Hospital". undefined are not yet recruiting, 17 are recruiting, 19 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 55 completed trials in Montreal Neurological Institute and Hospital, 1 suspended trials, and 18 terminated clinical trials to date.

Out of the total trials that were conducted in Montreal Neurological Institute and Hospital, 9 "Phase 1" clinical trials were conducted, 38 "Phase 2" clinical trials and 52 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 7 trials that are defined as “Not Applicable".